A high-level panel of experts has issued recommendations to accelerate recruitment for Alzheimer’s disease clinical trials. There is growing urgency to increase awareness and recruitment for studies on Alzheimer’s disease, many of which need to enroll healthy volunteers as well as people with the disease, to find effective treatments and preventive strategies. Their conclusions were published in Alzheimer’s & Dementia, the Journal of the Alzheimer’s Association.
